Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IBIDY | ADBE |
|---|---|---|
| Price | $40.24 | $238.79 |
| Change today | ▼ 3.04% | ▲ 0.46% |
| Market cap | $92.89B | $92.94B |
| Return, 3 months | +12.3% | +7.8% |
| Return, year to date | +303.1% | -31.8% |
| Return, 1 year | +593.7% | -31.8% |
| P/E (TTM) | 223.6 | 13.3 |
| P/B | 24.9 | 7.9 |
| P/E percentile vs own 5y | – | 5th |
| Dividend yield | 0.11% | – |
| Revenue growth (YoY, latest qtr) | – | +12.9% |
| Net profit growth (YoY) | – | +3.1% |
| Gross margin | – | 89.3% |
| Operating margin | – | 35.7% |
| Net margin | – | 28.0% |
| Return on equity | – | 61.9% |
| Analyst target vs. price | – | +14.3% |
| Analyst buy share | – | 36% |
| RSI (14) | 69 | 42 |
| 30-day volatility | 71.8% | 41.5% |
| Max drawdown, 1 year | -52.2% | -46.5% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
